BRPI0515125A - conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina - Google Patents

conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina

Info

Publication number
BRPI0515125A
BRPI0515125A BRPI0515125-2A BRPI0515125A BRPI0515125A BR PI0515125 A BRPI0515125 A BR PI0515125A BR PI0515125 A BRPI0515125 A BR PI0515125A BR PI0515125 A BRPI0515125 A BR PI0515125A
Authority
BR
Brazil
Prior art keywords
protein
derivatized
conjugates
vaccine
polysaccharide conjugates
Prior art date
Application number
BRPI0515125-2A
Other languages
English (en)
Inventor
Robert P Ryall
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of BRPI0515125A publication Critical patent/BRPI0515125A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/116Polyvalent bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

CONJUGADOS DE POLISSACARìDEO DERIVATIZADO-PROTEìNA MULTIVALENTES, MENINGOCóCICOS E VACINA. A presente invenção refere-se a conjugados de polissacarídeo derivatizado-proteína, uma composição compreendendo um ou mais de tais conjugados de polissacarídeo derivatizado e métodos para imunização de pacientes humanos com os mesmos. Os conjugados de polissacarídeo derivatizado-proteína são polissacarídeos capsulares purificados dos sorogrupos de Neisseria meningitidis A, C, W-135 e Y, derivatizados, ativados químicamente e anexados seletivamente a uma proteína veículo por meio de uma ligação química covalente, formando conjugados de polissacarídeo-proteína capazes de promover a imunidade de longa duração contra várias cepas de N. meningitidis.
BRPI0515125-2A 2004-08-30 2005-08-29 conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina BRPI0515125A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60557904P 2004-08-30 2004-08-30
PCT/US2005/031034 WO2006026689A2 (en) 2004-08-30 2005-08-29 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Publications (1)

Publication Number Publication Date
BRPI0515125A true BRPI0515125A (pt) 2008-07-08

Family

ID=36000720

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0515125-2A BRPI0515125A (pt) 2004-08-30 2005-08-29 conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina

Country Status (11)

Country Link
US (1) US20060088554A1 (pt)
EP (2) EP1784214A4 (pt)
JP (2) JP2008517876A (pt)
KR (1) KR20070101207A (pt)
CN (2) CN101048177A (pt)
AU (1) AU2005279821A1 (pt)
BR (1) BRPI0515125A (pt)
CA (1) CA2577920A1 (pt)
IL (1) IL181551A0 (pt)
WO (1) WO2006026689A2 (pt)
ZA (1) ZA200701675B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513541A (ja) * 2004-09-21 2008-05-01 サノフィ パストゥール インコーポレイテッド 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン
US10828361B2 (en) 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
PL2004225T3 (pl) 2006-03-22 2012-09-28 Novartis Ag Schematy immunizacji koniugatami meningokokowymi
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
WO2013046226A2 (en) * 2011-08-04 2013-04-04 Serum Institute Of India Ltd. A novel quantification method for vaccines
CN103007268A (zh) * 2012-12-26 2013-04-03 天津康希诺生物技术有限公司 一种低剂量多价结合疫苗组合物及用途
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
KR102906912B1 (ko) 2016-09-02 2026-01-05 사노피 파스퇴르 인크 네이세리아 메닌기티디스 백신

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
OA12590A (en) * 2001-01-23 2006-06-08 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine.
AU2002309706A1 (en) * 2001-05-11 2002-11-25 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
PT1777236T (pt) * 2002-03-26 2017-02-13 Glaxosmithkline Biologicals Sa Sacáridos modificados possuindo estabilidade melhorada em água para utilização como um medicamento
CA2524853A1 (en) * 2003-05-07 2005-01-20 Aventis Pasteur, Inc. Method of enhanced immunogenicity to meningococcal vaccination
CN1852733A (zh) * 2003-05-07 2006-10-25 安万特巴斯德公司 多价脑膜炎球菌衍生的多糖-蛋白质缀合物及疫苗
JP2008513541A (ja) * 2004-09-21 2008-05-01 サノフィ パストゥール インコーポレイテッド 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン

Also Published As

Publication number Publication date
CN101048177A (zh) 2007-10-03
JP2008517876A (ja) 2008-05-29
EP1784214A2 (en) 2007-05-16
EP1784214A4 (en) 2009-09-23
KR20070101207A (ko) 2007-10-16
JP2012140456A (ja) 2012-07-26
WO2006026689A2 (en) 2006-03-09
CN101934077A (zh) 2011-01-05
CA2577920A1 (en) 2006-03-09
AU2005279821A1 (en) 2006-03-09
ZA200701675B (en) 2008-11-26
US20060088554A1 (en) 2006-04-27
EP2351582A1 (en) 2011-08-03
WO2006026689A3 (en) 2006-07-27
IL181551A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
BRPI0410341B8 (pt) conjugados de polissacarídeo-proteína derivatizados de meningococos multivalentes e vacina
EA201101164A1 (ru) Иммуногенная композиция
BRPI0612670B8 (pt) composição imunogênica, vacina a compreendendo e kit de vacina para a administração concomitante ou sequencial
BRPI0206672B8 (pt) composição imunológica, vacina conjugada tetravalente e vacina meningocócica multivalente
BRPI0411875A (pt) método de imunização contra os sorogrupos a e c de neisseria meningitidis
CR10123A (es) Vacuna.
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
BR112012007876A2 (pt) "membranas de troca de íons"
BRPI0515520A (pt) composição imunogênica, vacina, métodos de preparar uma vacina e de prevenir ou tratar infecção estafilocócica, e, uso de composição imunogênica
BRPI0607374A2 (pt) vacinas de vesìculas baseadas em gna1870 para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
JP2007533729A5 (pt)
CY1119940T1 (el) Παραγοντας για χρηση στην περιπτωση δυσανεξιας στη φρουκτοζη
BRPI0515125A (pt) conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina
MY199399A (en) Novel polysaccharide-protein conjugates and process to obtain thereof
BRPI0516770A (pt) vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente
CY1123600T1 (el) Μεθοδος θεραπειας
WO2005003775A3 (en) Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
WO2006002402A3 (en) Polysaccharide derivatives and uses in induction of an immune response
BRPI0516372A (pt) conjugados de polissacarìdeo-proteìna derivatizados meningocócicos multivalentes e vacina
BRPI0411815A (pt) vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
UA97359C2 (en) Immunogenic composition
BR112012007877A2 (pt) meios e métodos para produção de polissacarídeos capsulares artificiais de neisseria meningitidis
JO3420B1 (ar) تركيبة صيدلانية ولقاح للوقاية من اصابات المكورة العقدية
RU2008131066A (ru) Фармацевтическая композиция, содержащая белок nma0939
AR095579A1 (es) Procedimiento de inmunización

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2269 DE 01/07/2014.